United States · Bill · HR
H.R. 5632 (117th)
Long-Term Care Pharmacy Definition Act of 2021
Introduced
19 October 2021
Last action
20 October 2021 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Schrader, Kurt [D-OR-5], Sen. Mullin, Markwayne [R-OK], Rep. O'Halleran, Tom [D-AZ-1], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Guest, Michael [R-MS-3], Rep. Harshbarger, Diana [R-TN-1], Rep. Schneider, Bradley Scott [D-IL-10], Rep. Long, Billy [R-MO-7], Rep. McBath, Lucy [D-GA-6], Rep. Butterfield, G. K. [D-NC-1], Rep. Comer, James [R-KY-1], Rep. Smith, Adrian [R-NE-3], Rep. Rutherford, John H. [R-FL-5], Rep. Davids, Sharice [D-KS-3], Rep. Griffith, H. Morgan [R-VA-9], Rep. Guthrie, Brett [R-KY-2], Rep. Grothman, Glenn [R-WI-6], Rep. Bacon, Don [R-NE-2], Rep. Allen, Rick W. [R-GA-12], Jake LaTurner
Subjects
Healthcare
Source updated
5 December 2025
Summary
Long-Term Care Pharmacy Definition Act of 2021 This bill establishes a statutory definition for long-term care pharmacy under the Medicare prescription drug benefit. Currently, there is no statutory definition. Regulations from the Centers for Medicare & Medicaid Services (CMS) define a long-term care pharmacy as a pharmacy that is owned by or under contract with a long-term care facility to provide prescription drugs to the facility's residents. Additional requirements are set out in CMS guidance relating to the Medicare prescription drug benefit; pharmacies are also subject to regulations and guidance from other agencies (e.g., packaging requirements from the Food and Drug Administration). The bill defines a long-term care pharmacy as a state-licensed pharmacy that is able to provide enhanced pharmacy and clinical services to individuals who have certain comorbid and medically complex chronic conditions and who reside in skilled nursing facilities, nursing facilities, or any other applicable setting (as determined by the CMS). The term enhanced pharmacy and clinical services includes medication dispensed in special packaging, drug utilization review, and 24-7 availability of medication delivery and on-call pharmacists.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 October 2021
Referred
Referred to the Subcommittee on Health.
Source: Committee
19 October 2021
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
19 October 2021
Introduced
Introduced in House
Source: IntroReferral
19 October 2021
Introduced
Introduced in House
Source: IntroReferral
20 October 2021
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 19 October 2021 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 19 October 2021
Introduced in House (PDF)
Introduced in House · EN · 19 October 2021
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 19 October 2021
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Schrader, Kurt [D-OR-5] · D · Sponsor
- Sen. Mullin, Markwayne [R-OK] · R · Sponsor
- Rep. O'Halleran, Tom [D-AZ-1] · D · Cosponsor
- Rep. Carter, Earl L. "Buddy" [R-GA-1] · R · Cosponsor
- Rep. Guest, Michael [R-MS-3] · R · Cosponsor
- Rep. Harshbarger, Diana [R-TN-1] · R · Cosponsor
- Rep. Schneider, Bradley Scott [D-IL-10] · D · Cosponsor
- Rep. Long, Billy [R-MO-7] · R · Cosponsor
- Rep. McBath, Lucy [D-GA-6] · D · Cosponsor
- Rep. Butterfield, G. K. [D-NC-1] · D · Cosponsor
- Rep. Comer, James [R-KY-1] · R · Cosponsor
- Rep. Smith, Adrian [R-NE-3] · R · Cosponsor
- Rep. Rutherford, John H. [R-FL-5] · R · Cosponsor
- Rep. Davids, Sharice [D-KS-3] · D · Cosponsor
- Rep. Griffith, H. Morgan [R-VA-9] · R · Cosponsor
- Rep. Guthrie, Brett [R-KY-2] · R · Cosponsor
- Rep. Grothman, Glenn [R-WI-6] · R · Cosponsor
- Rep. Bacon, Don [R-NE-2] · R · Cosponsor
- Rep. Allen, Rick W. [R-GA-12] · R · Cosponsor
- Jake LaTurner · R · Cosponsor
- · hsif00 · Standing
- · hswm00 · Standing
Related records
- related to → Long-Term Care Pharmacy Definition Act of 2021
- related to ← Long-Term Care Pharmacy Definition Act of 2020
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/5632
- Open data entity: https://api.congress.gov/v3/bill/117/hr/5632
- us · 117-hr-5632 · source updated 5 December 2025